project id: TCGA-LUAD; case submitter id: TCGA-MP-A4TD; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 71; days to birth: -25983; days to death: 307; ethnicity: not reported; gender: male; race: white; vital status: Dead; year of birth: 1937; year of death: 2008; age at diagnosis: 25983; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2008; alcohol history: Not Reported; cigarettes per day: 1.095890410958904; pack years smoked: 20.0; is ffpe: false; composition: Not Reported; days to collection: 1471; days to sample procurement: 0; initial weight: 230.0; portion submitter id: TCGA-MP-A4TD-01A-32; percent lymphocyte infiltration: 15.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 65.0; percent tumor cells: 35.0; percent tumor nuclei: 90.0;